XVir-N-31 also repressed the growth of bladder cancer cells with strong YB-1 expression in vitro and intra-tumor delivery significantly repressed tumor volume in vivo (Lichtenegger et al., 2018). Here, YBX1 is linked to urinary bladder carcinoma.